Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMNR - Immune Response -- Ignore unavailable to you. Want to Upgrade?

To: Marshall Teitelbaum who wrote (210)	1/22/1998 8:47:00 AM
From: BONZ	Read Replies (1) \| Respond to of 1510

NEWS biz.yahoo.com

To: Marshall Teitelbaum who wrote (210)	1/30/1998 10:19:00 AM
From: Harry D. Kramer	Respond to of 1510

Hi Marshall, nice to see you on the IMNR thread. Sorry for the delay in answering, but I have been offline for quite some time. Thanks, for bringing the insider sales up. I actually have seen this and tried to get some infos on that, but the company didn't want to comment on the Glavin sale, which was actually the second time he sold shares within the last few months. I did, however, hear the word that there are personal reasons behind his sales and that it has nothing to do with his perception of the company's prospects. Either way, I don't like to see this again and especially I don't want to see other insiders doing the same. So far I don't worry too much about it. I like the developments in the R&D pipeline so far, and I hope we will get a first glimpse at the potential of Remune within the next few months. Trading volume has been very low in the last few weeks. I haven't made up my mind whether this is a good sign (as we are in a downtrend), or we should take this as a worrysome sign. Are you long IMNR? Hope we have a nice day (ATIS), but I don't think it will be as exciting as some of the short-term traders think. Harry